Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Opioids Commonly Prescribed for Gout Attacks

Reuters Staff  |  July 9, 2019

NEW YORK (Reuters Health)—Nearly three in 10 patients seeking care at the emergency department (ED) for acute gout will be discharged with a prescription for opioids, new research shows.

“Our study suggests a high use of prescription opioid in patients discharged from the ED with a diagnosis of gout, a condition that can be managed effectively with other medications,” Deepan S. Dalal, MD, of Brown University Warren Alpert School of Medicine, Providence, and colleagues write.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Steroids, non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine can reduce pain and inflammation from gout attacks, the authors note in Arthritis Care and Research, online July 3.1

“Despite the efficacy of conventional agents, empirical evidence suggests common use of opioid analgesics in gout management,” they add.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The authors looked at Lifespan Healthcare Systems data on 456 patients discharged from the ED or hospital after treatment of acute gout between 2015 and 2017. At discharge, 28.3% were prescribed an opioid, 79% had not been on opioid medications previously.

The average dose was 37.9 mg of morphine equivalent for a median eight days.

Opioid prescription type was available for 119 patients, including 81% prescribed oxycodone or combinations of oxycodone, 8% prescribed hydrocodone and 9% prescribed tramadol.

Patients prescribed opioids at discharge were more likely to have diabetes, hypertension and substance abuse, and were also more likely to be using opioids at the time of admission. Patients with polyarticular gout attacks were also more likely to receive opioids at discharge.

“In addition to regulatory changes, the burden of opioid prescription could be potentially reduced by creating prompts for providers in electronic record system to avoid prescribing opioids in opioid-naive patients OR using lower intensity and shorter duration of prescription,” Dr. Dalal and colleagues write.

“Future prospective studies assessing the reasons for prescription of opioids may provide further insight into strategies to reduce the burden of prescription opioids,” they add.

Dr. Dalal was not available for an interview by press time.


Reference

  1. Dalal DS, Mbuyi N, Shah I, et al. Prescription opioid use among acute gout patients discharged from the emergency department. Arthritis Care Res (Hoboken). 2019 Jul 2. [Epub ahead of print]

Share: 

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:Arthritis Care & ResearchEmergency DepartmentGoutopioidPainPain Management

Related Articles

    High Opioid Prescription Rates Seen in Emergency Department-Treated Gout

    November 2, 2020

    Acute gout can be very painful, causing patients to seek treatment in the emergency department. A retrospective study of pain interventions for gout in Rhode  Island found that nearly 30% of patients received prescriptions for opioid medications over 30 months. Of these prescriptions, over 80% were for patients who had never been exposed to opioids…

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences